Advancing excellence in laboratory medicine for better healthcare worldwide

2017 Publications of Interest

C-NPU - Nomenclature, Properties and Units -  Joint Committee of IFCC/IUPAC

  1. Wikipedia page for the NPU Terminology:
    https://en.wikipedia.org/wiki/NPU_terminology
  2. Flatman R, Gerard G, Dybkaer R, IFCC-IUPAC Joint Committee on Nomenclature, Properties and Units (C-NPU), Understanding the "Silver Book" - An important reference for standardised nomenclature in clinical laboratory sciences. Clinica Chimica Acta, Volume 467, April 2017, Pages 4-7.
  3. Document  prepared in the frame of IUPAC Project # 2004-023-1-700, extended 2008-019-1-700. Vocabulary on nominal property, examination, and related concepts for clinical laboratory sciences (IFCC-IUPAC Recommendations 2017). Pure Appl. Chem. 2018; 90(5): 913–935

C-MD - Molecular Diagnostics 

  1. Payne DA, Baluchova K, Peoc'h KH, van Schaik RHN, Chan  KC Allen,  Maekawa M, Mamotte C, Russomando G, Rousseau  F,  Ahmad-Nejad  P, on behalf of the IFCC Committee for Molecular Diagnostics (C-MD).   Pre-examination factors affecting molecular diagnostic test results and interpretation: A case-based approach. Clinica Chimica Acta, 2017 Apr; 467:59-69. doi: 10.1016/j.cca.2016.06.018.

C-RIDL - Reference Intervals and Decision Limits   

  1. 1. Ichihara K, Ozarda Y, Barth JH, Klee G, Ling Q, Erasmus R, et al. on behalf of the Committee on Reference Intervals and Decision Limits, International Federation for Clinical Chemistry and Laboratory Medicine. A global multicenter study on reference values: 1. Assessment of methods for derivation and comparison of reference intervals. Clinica Chimica Acta. 2017 Apr;467:70-82. doi: 10.1016/j.cca.2016.09.016.
  2. Ichihara K, Ozarda Y, Barth JH, Klee G, Shimizu Y, Xia L, et al. on behalf of the Committee on Reference Intervals and Decision Limits, International Federation for Clinical Chemistry and Laboratory Medicine. A global multicenter study on reference values: 2. exploration of sources of variation across the countries. Clinica Chimica Acta. 2017 Apr;467:83-97. doi: 10.1016/j.cca.2016.09.015.

Other articles directly related to the C-RIDL projects.

  1. Ozarda Y, Ichihara K, Bakan E, Polat H, Ozturk N, Baygutalp NK, et al. A nationwide multicentre study in Turkey for establishing reference intervals of haematological parameters with novel use of a panel of whole blood. Biochem Med 2017; 27(2):350-377.

C-STFT - Standardisation of Thyroid Function Tests

  1. Thienpont LM, Van Uytfanghe K, De Grande LAC, Reynders D, Das B, Faix JD, MacKenzie F, Decallonne B, Hishinuma A, Lapauw B, Taelman P, Van Crombrugge P, Van den Bruel A, Velkeniers B, Williams P on behalf for the IFCC Committee for Standardization of Thyroid Function Tests (C-STFT). Harmonization of Serum Thyroid-Stimulating Hormone Measurements Paves the Way for the Adoption of a More Uniform Reference Interval. Clin Chem 2017;63:1248-60.
  2. De Grande LAC, Van Uytfanghe K, Reynders D, Das B, Faix JD, MacKenzie F, Decallonne B, Hishinuma A, Lapauw B, Taelman P, Van Crombrugge P,Van den Bruel A, Velkeniers B, Williams P, Thienpont LM on behalf for the IFCC Committee for Standardization of Thyroid Function Tests (C-STFT). Standardization of free thyroxine measurements paves the way
    for the adoption of a more uniform reference interval. Clin Chem 2017; 63:1642-52.

Additional related publications:

  1. De Grande LA, Goossens K, Van Uytfanghe K, Das B, MacKenzie F, Patru MM, Thienpont LM; IFCC Committee for Standardization of Thyroid Function Tests (C-STFT). Monitoring the stability of the standardization status of FT4 and TSH assays by use of daily outpatient medians and flagging frequencies. Clinica Chimica Acta. 2017 Apr;467:8-14. doi: 10.1016/j.cca.2016.04.032.
  2. De Grande LA, Goossens K, Van Uytfanghe K, Halsall I, Yoshimura Noh J, Hens K, Thienpont LM. Using “big data” to describe the effect of seasonal variation in thyroidstimulating hormone. Clin Chem Lab Med. 2017; 55:e34–e36

WG- HbA2 - Standardisation of Hemoglobin A2

  1. Paleari R, Caruso D, Kaiser P, Arsene CG, Schaeffer-Reiss C, Van Dorsselaer A, Bissé E, Ospina M, De Jesús VR, Wild B, Mosca A, "Developing a reference system for the IFCC standardization of HbA2". Clinica Chimica Acta. 2017 Apr;467:21-26. doi: 10.1016/j.cca.2016.05.023. Epub 2016 May 27

WG-SCDT - Carbohydrate-Deficient Transferrin

  1. Schellenberg F, Wielders J, Anton R, Bianchi V, Deenmamode J, Weykamp C, Whitfield J, Jeppsson JO,  Helander A. IFCC approved HPLC reference measurement procedure for the alcohol consumption biomarker carbohydrate-deficient transferrin (CDT): Its validation and use. Clin Chim Acta. 2017 Feb;465:91-100. doi: 10.1016/j.cca.2016.12.022.
  2. Wielders J. International standardization of CDT measurement and interpretation improves its use as biomarker for chronic excessive alcohol consumption. IFCC eNews Nov-Dec, 2017, 12-13. https://www.ifcc.org/media/476786/ifccenewsdecember2017.pdf

WG-SAU - Standardization of Albumin Assay in Urine – in collaboration with NKDEP

  1. Miller WG, Seegmiller JC, Lieske JC, Narva AS, Bachmann LM. Standardization of Urine Albumin Measurements: Status and Performance Goals. The Journal of Applied Laboratory Medicine. Sep 2017, jalm.2017.023614; DOI: 10.1373/jalm.2017.02361
  2. Seegmiller JC, Miller WG, Bachmann LM. Moving towards standardization of urine albumin measurements. eJIFCC 2017 - Vol 28 No 4, https://www.ifcc.org/media/476804/ejifcc2017vol28no4pp258-267.pdf

WG-cMSP - Quantitative Mass Spectrometry Proteomics

  1. Lehmann S, Brede C, Lescuyer P, Cocho JA, Vialaret J, Bros P, Delatour V, Hirtz V and the IFCC WG-cMSP.  Clinical Mass spectrometry proteomics (cMSP) for medical laboratory: what could be the future? Clinica Chimica Acta. 2017 Apr; 467:51-58. doi: 10.1016/j.cca.2016.06.001. Editor P Gillery.

WG-PTH - Parathyroid Hormone 

  1. CM Sturgeon, S Sprague, A Almond, E Cavalier, WD Fraser, Algeciras-Schimnich A, et al. Perspective and priorities for improvement of parathyroid hormone (PTH) measurement – A view from the IFCC Working Group for PTH. Clinica Chimica Acta Volume 467, April 2017, Pages 42-47.

Other publications:

  1. Working group members also contributed to the articles described above in Kidney News (American Society of Nephrology), Clinical Laboratory News (AACC) and an article on PTH for the Encyclopedia of Endocrinology.

WG-CSF - CSF-Proteins

  1. Pannee J, Blennow K, Zetterberg H, Portelius E. Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure. J Vis Exp 2017;(121).
  2. Janelidze S, Pannee J, Mikulskis A, Chiao P, Zetterberg H, Blennow K, Hansson O. Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment. JAMA Neurol. 2017 Dec 1;74(12):1492-1501. doi: 10.1001/jamaneurol.2017.2814.

Other publications:

  1. The work of the IFCC WG-CSF has been summarized in a review paper that is submitted to the CCA special issue:
    Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, Korecka M, Jenkins RG, Vanderstichele H, Stoops E, Lewczuk P, Shaw LM, Zegers I, Schimmel h, Zetterberg H, Blennow K, on behalf of the IFCC Working Group on Standardisation of CSF proteins (WG-CSF). CSF Aβ1-42 – an excellent but complicated Alzheimer’s biomarker – a route to standardization. Clinica Chimica Acta 2017;467:27-33.

 
Website developed by Insoft